Punganuru et al. reported that R-goniothalamin induced ROS generation at three hours of treatment in SKBR3 breast cancer cells harboring an R175H mutant p53 and that reactive oxygen species (ROS) were subsequently conjugated with glutathione making the ROS level decline [36]. Here, TP53 is linked to breast carcinoma.